Introduction {#Sec1}
============

Over 500,000 Americans suffer a cardiac arrest (CA) annually \[[@CR1]\]. Among those with return of spontaneous circulation (ROSC), 50 to 60% do not survive to hospital discharge \[[@CR2],[@CR3]\]. The post-arrest syndrome develops commonly after CA, and is characterized by multiple organ dysfunction secondary to global ischemia-reperfusion injury and a systemic inflammatory response \[[@CR4]-[@CR6]\]. Pulmonary dysfunction and the acute respiratory distress syndrome (ARDS) are components of this process.

Observational studies have associated higher arterial oxygen concentration (hyperoxia) with worsened clinical outcomes \[[@CR7]-[@CR10]\]. Authors of these studies have hypothesized that this effect is mediated through worsening of secondary brain injury by increased oxidative stress and free radical formation, but other possible explanations for this association have not been previously explored. In the lung, oxygen exposure may to lead to ARDS through free-radical formation \[[@CR11],[@CR12]\], and although isolated respiratory failure is an uncommon proximate cause of death after CA, lung dysfunction is common and may worsen patient outcomes \[[@CR13]\]. Preclinical data suggest that high concentrations of oxygen cause pulmonary endothelial apoptotic cell death and worsened lung injury \[[@CR14]-[@CR17]\]. However, there is an important interaction between tidal volume (that is, stretch-induced lung injury) and oxygen toxicity that may explain this observation \[[@CR18],[@CR19]\]. Indeed, early clinical reports of pulmonary oxygen toxicity were conducted when open-lung ventilation with high tidal volumes was standard practice \[[@CR20]-[@CR22]\].

CA patients are often exposed to 100% oxygen during cardiopulmonary resuscitation (CPR) and early after ROSC \[[@CR10]\]. Thus, this cohort is theoretically at risk for oxygen-induced lung toxicity, which might help explain the association between hyperoxia and patient outcomes. Respiratory failure based on a higher sequential organ failure assessment (SOFA) score has been associated with increased mortality in two studies of CA outcomes \[[@CR23],[@CR24]\]. We analyzed data from a high-resolution CA database to test the hypothesis that cumulative dose of inhaled oxygen to which patients are exposed after CA is associated with deterioration in lung function in the first 48 h after ROSC. Second, we tested the association between inhaled oxygen exposure and clinically relevant patient outcomes including survival to hospital discharge and neurological outcome.

Materials and methods {#Sec2}
=====================

Patients and setting {#Sec3}
--------------------

We analyzed a prospective database of consecutive in- and out-of-hospital CA patients cared for at UPMC Presbyterian hospital by the Post-Cardiac Arrest Service (PCAS). UPMC Presbyterian is a 798-bed tertiary care center with approximately 54,000 emergency department visits annually and 150 ICU beds. The PCAS treats over 350 survivors of CA annually and is part of local efforts to regionalize and improve CA care. We have implemented hospital-wide protocols to standardize and improve post-CA care \[[@CR25]\].

We included CA patients presenting between October 2008 (when electronic medical records were implemented system-wide, permitting recording of vital signs and ventilator data) and April 2010, who had a CA with ROSC, survived and were mechanically ventilated for a least 24 h. We included both in- and out-of-hospital CA patients because 1) this reflects the true heterogeneity encountered in clinical practice, 2) we hypothesized that post-arrest organ dysfunction would be primarily dependent on ischemia and reperfusion injury rather than pathology present antecedent to the arrest, and 3) we have previously demonstrated that the affect of cardiopulmonary dysfunction on patient outcomes is stable across arrest location \[[@CR23]\]. We excluded patients if the time of ROSC was unknown, if vital signs and vasopressor requirements were not recorded within 6 h of ROSC, or if arterial blood gas (ABG) or ventilator data were not recorded within 4 h of ROSC (we have previously reported that this is the timeframe during which patients are most often exposed to high fraction of inspired oxygen (FiO~2~) levels \[[@CR10]\]). We further excluded patients managed with extracorporeal membrane oxygenation. The University of Pittsburgh Institutional Review Board approved all aspects of this study with a waiver of informed consent.

Primary exposure and covariates {#Sec4}
-------------------------------

Our primary exposure of interest was inhaled oxygen. To quantify this exposure, we calculated the area under the curve (AUC) of the FiO~2~ (FiO~2~AUC) for each patient as follows. First, we recorded FiO~2~ values hourly for 24 h after ROSC. Based on our local practice, we assumed all patients were ventilated with an FiO~2~ of 1.0 during their initial resuscitation until the first recorded value \[[@CR10]\]. Next, we summed these hourly values to derive the FiO~2~AUC. This FiO~2~AUC could theoretically range from 5 (24 h on room air at FiO~2~ = 0.21) to 24 (24 h on FiO~2~ = 1.0).

We abstracted demographic and basic clinical information from our prospective CA registry, including subject age, gender, location of arrest (out-of-hospital versus in-hospital), initial arrest rhythm (ventricular tachycardia or fibrillation (VT/VF) versus pulseless electrical activity (PEA) or asystole) and use of hypothermia. Additionally we abstracted each subject's Pittsburgh CA Category (PCAC). The PCAC is a clinical prediction tool that stratifies post-arrest patients by their risk of subsequent death or neurological deterioration based on clinical characteristics during the first 6 h after ROSC \[[@CR23]\]. This tool divides patients into four categories that are strongly predictive of survival and functional outcome.

We assessed baseline post-arrest pulmonary dysfunction by recording each patient's initial partial pressure of arterial oxygen (PaO~2~):FiO~2~ (P:F) ratio and dynamic pulmonary compliance, which we calculated as equal to tidal volume/(peak inspiratory pressure minus positive end-expiratory pressure (PEEP)). Additionally, we calculated the respiratory subscale of the SOFA scale (SOFA-R) \[[@CR26]\]. To quantify the degree of post-arrest cardiovascular dysfunction, we calculated the baseline cardiovascular subscale of the SOFA score (SOFA-CV), cumulative vasopressor index (CVI), and shock index (mean arterial pressure/heart rate). The SOFA score is a validated measure of organ dysfunction commonly used in critical care research \[[@CR26]\]. The respiratory subscale assigns 0 to 4 points based on the P:F ratio and requirement for mechanical ventilation and the cardiovascular subscale assigns 0 to 4 points based on the presence of hypotension and vasoactive medication requirement. The CVI is a method of standardizing vasopressor dosing \[[@CR26],[@CR27]\]. We calculated the CVI from the highest vasopressor dose needed to achieve a mean arterial pressure (MAP) \>70 mmHg within the first 6 h after ROSC.

Missing data {#Sec5}
------------

The baseline data necessary to calculate each patient's baseline SOFA score were unavailable in the first 6 h in a small number of cases. In this situation, we used data within 12 h of the time of interest. When PaO~2~ data were unavailable even within 12 h of a given time point (3.2% of cases), we calculated SOFA-R using peripheral oxygen saturation (SpO~2~) which is recorded hourly based on the following table, which we developed on the basis of a previously validated SpO~2~:FiO~2~ estimation for P:F ratio \[[@CR28]\].

Outcomes {#Sec6}
--------

The primary outcomes of interest were the change in SOFA-R and dynamic pulmonary compliance over the first 48 h after admission, and second, the changes in SOFA-R and dynamic pulmonary compliance from 0 to 24 h and 0 to 72 h. As lung injury develops over hours-to-days after the initial inflammatory or injurious insult, we chose these time points to ensure we fully captured the sequelae of the initial exposure \[[@CR29]\]. Additional secondary outcomes of interest were 1) survival to hospital discharge, and 2) neurological outcomes, which we assessed by measuring the Pittsburgh cerebral performance category (CPC) at hospital discharge.

Statistical analysis {#Sec7}
--------------------

We used Stata Version 13.1 (StataCorp, College Station, TX, USA) for our analyses. We used linear regression to test the association between baseline characteristics and FiO~2~AUC. Next, we explored the association between FiO~2~AUC and change in SOFA-R (using ordered logistic regression) and change in dynamic pulmonary compliance (using linear regression). Finally, we investigated the association between FiO~2~AUC and survival (using unadjusted and multiple logistic regression) and neurological outcome (using unadjusted and multiple ordered logistic regression). In the adjusted models we included only variables with unadjusted associations having outcomes with *P*-values \<0.2, to avoid over-fitting. We confirmed the validity of the proportional odds assumption for ordered logistic regression test procedures. As a *post hoc* analysis, to determine whether baseline pulmonary dysfunction or change in pulmonary dysfunction differed between the in-hospital and out-of-hospital arrest populations, we stratified patients by arrest location and compared their baseline SOFA-R, dynamic pulmonary compliance and the change in these values from baseline to 72 h and 24 to 72 h using Fisher's exact tests and *t*-tests as appropriate.

To evaluate the possibility of a threshold effect for an association between oxygen exposure and clinical outcomes, we divided the population into quartiles based on FiO~2~AUC and compared survival and neurological outcome between these quartiles. Finally, to address the possibility of confounding by indication (that is, severity of illness may lead both to exposure to higher FiO~2~AUC and to worse outcomes in the absence of causality), we performed a propensity-adjusted analysis. We generated a saturated propensity score incorporating all baseline covariates to model the propensity for exposure to a higher quartile of FiO~2~AUC given baseline clinical characteristics, and then calculated the inverse probability of treatment weight (IPTW) using the inverse of the propensity score and a weight to reflect the sample size of each treatment group \[[@CR30],[@CR31]\]. After checking for and removing any extreme outlier IPTW values, we constructed adjusted models using the IPTW to test for an independent association between FiO~2~AUC quartile and change in SOFA-R and dynamic pulmonary compliance from 0 to 48 h, as well as overall survival.

Results {#Sec8}
=======

Cohort characteristics {#Sec9}
----------------------

Our initial registry query yielded 187 CA patients, of whom 17 were transferred from outlying facilities late in their post-arrest course and therefore excluded for missing post-ROSC ABG, vital sign or ventilator data based on our exclusion criteria, leaving 170 patients for analysis. Mean age was 60 ± 6 years and 52% were male (Table [1](#Tab1){ref-type="table"}). The baseline PaO~2~:FiO~2~ ratio was 241 ± 137, and quantified using SOFA subscales, 85% of patients had baseline pulmonary failure while 55% had cardiovascular failure. Overall, pulmonary compliance and SOFA-R scores improved daily, with a mean change in SOFA-R of −0.7 ± 1.4 and a mean change in dynamic pulmonary compliance of 3.8 ± 18.4 mL/cmH~2~O at 48 h (Table [2](#Tab2){ref-type="table"}). Neither baseline measure of pulmonary dysfunction nor change from baseline to 72 h or change from 24 to 72 h differed across arrest location (data not shown). Patients with an initial arrest rhythm of VT/VF, lower initial PaO~2~:FiO~2~ ratio, and more severe shock were exposed to higher FiO~2~AUCs (Table [3](#Tab3){ref-type="table"}).Table 1**Baseline population characteristicsCharacteristicOverallNon-survivorsSurvivors(n = 170)(n = 95)(n = 75)Demographics**Age, years60 ± 1659 ± 1763 ± 15Male sex89 (52%)54 (61%)35 (40%)**Arrest characteristics**Out-of-hospital arrest96 (56%)58 (61%)38 (51%)Initial rhythm VT/VF64 (38%)31 (33%)33 (44%)Therapeutic hypothermia used113 (66%)76 (80%)37 (49%)Pittsburgh cardiac arrest category 128 (16%)9 (9%)19 (25%) 263 (37%)26 (27%)37 (49%) 332 (19%)19 (20%)13 (17%) 447 (28%)41 (43%)6 (8%)**Baseline physiologic and ventilator data**First PaO~2~:FiO~2~ ratio241 ± 137249 ± 129231 ± 146Dynamic compliance, mL/cm H~2~O29 ± 1229 ± 1228 ± 13Initial SOFA-respiratory score 026 (15%)13 (14%)13 (17%) 133 (19%)24 (25%)9 (12%) 233 (19%)17 (18%)16 (21%) 346 (27%)26 (27%)20 (27%) 432 (19%)15 (16%)17 (23%)Initial SOFA-cardiovascular score 076 (45%)33 (35%)43 (57%) 118 (11%)8 (8%)10 (13%) 210 (6%)9 (9%)1 (1%) 331 (18%)22 (23%)9 (12%) 425 (21%)23 (24%)12 (16%)Cumulative vasopressor index1.4 ± 1.91.7 ± 1.91.1 ± 1.9Time to first FiO~2~ wean, h6.3 ± 6.46.8 ± 6.95.8 ± 5.6Number of FiO~2~ changes in 24 h2.5 ± 1.52.5 ± 1.62.6 ± 1.4Data are presented as mean (standard deviation) or raw number with corresponding percentage. *VT/VF,* ventricular tachycardia/fibrillation; *PaO* ~*2*~ *,* partial pressure of arterial oxygen; *FiO* ~*2*~ *,* fraction of inspired oxygen; *SOFA,* sequential organ failure assessment.Table 2**Population physiological and neurological outcomesOutcomeOverall cohort(n = 170)**Change in SOFA-respiratory score 0 to 24 h−0.3 (1.5) 0 to 48 h−0.7 (1.4) 0 to 72 h−0.9 (1.5)Change in lung compliance, ml/cmH~2~O 0 to 24 h0.5 (13.9) 0 to 48 h3.8 (18.4) 0 to 72 h4.9 (21.0)Discharge CPC 18 (5%) 21 (1%) 358 (34%) 47 (4%) 594 (56%)Survival to hospital discharge75 (44%)Data are presented as mean (standard deviation) or raw number with corresponding percentage. *SOFA,* sequential organ failure assessment; *CPC,* cerebral performance category.Table 3**Unadjusted association between oxygen exposure over the first 24 h after ROSC (FIO** ~**2**~ **AUC) and baseline arrest and cardiopulmonary characteristicsBaseline predictorB coefficient (95% CI)*P*** **-value**Age−0.035 (−0.069 to −0.001)0.04Male sex0.438 (−0.658 to 1.535)0.43Out-of-hospital arrest0.304 (−0.802 to 1.410)0.59Arrest rhythm VT/VF1.306 (0.191 to 2.421)0.02Received TH0.355 (−0.806 to 1.516)0.55PCAC 1ReferenceReference 2−0.246 (−1.823 to 1.332)0.76 32.346 (0.548 to 4.143)0.01 40.441 (−1.217 to 2.100)0.60First P:F ratio per 25−0.262 (−0.354 to −0.170)\<0.001Initial pulmonary compliance0.010 (−0.035 to 0.054)0.67Initial SOFA-respiratory score 0ReferenceReference 11.246 (−0.481 to 2.973)0.16 21.703 (−0.024 to 3.430)0.05 33.431 (1.815 to 5.047)\<0.001 44.279 (2.540 to 6.018)\<0.001Initial SOFA-cardiovascular score 0ReferenceReference 1−1.190 (−3.040 to 0.660)0.21 20.145 (−2.230 to 2.519)0.90 31.092 (−2.230 to 2.600)0.15 41.245 (−0.197 to 2.686)0.09Initial cardiovascular index0.346 (0.061 to 0.630)0.02Time to first FiO~2~ wean0.012 (−0.074 to 0.099)0.78Number of FiO~2~ changes in 24 h−0.076 (−0.436 to 0.283)0.68*VT/VF,* ventricular tachycardia/ventricular fibrillation; *TH,* therapeutic hypothermia; *PCAC,* Pittsburgh cardiac arrest category; *P:F,* ratio of partial pressure of arterial oxygen (PaO~2~) to fraction of inspired oxygen (FiO~2~); *SOFA,* sequential organ failure assessment.

Pulmonary dysfunction {#Sec10}
---------------------

In unadjusted analysis, FiO~2~AUC was not significantly associated with increased SOFA-R from 0 to 48 h (Table [4](#Tab4){ref-type="table"}). No baseline predictors were associated with change in dynamic pulmonary compliance from 0 to 48 h (data not shown). In our adjusted model testing independent predictors of change in SOFA-R from 0 to 48 h, FiO~2~ remained non-significant (odds ratio (OR) 0.96 (95% confidence interval (CI) 0.88, 1.04), *P* = 0.34).Table 4**Unadjusted odds of change in the respiratory subscale of the Sequential Organ Failure Assessment score from 0 to 48 hPredictorUnadjusted odds ratio\* (95% CI)*P*** **-value**FiO~2~ AUC0.93 (0.86 to 1.02)0.11Age1.00 (0.98 to 1.02)0.86Male sex1.11 (0.62 to 2.00)0.72Out-of-hospital arrest2.02 (1.11 to 3.67)0.02Arrest rhythm VT/VF1.09 (0.78 to 2.00)0.78Received TH2.74 (1.43 to 5.25)\<0.01PCAC 1ReferenceReference 22.24 (0.88 to 5.70)0.09 30.87 (0.32 to 2.42)0.80 42.58 (0.97 to 6.84)0.06Initial pulmonary compliance0.98 (0.95 to 1.01)0.24Initial SOFA-cardiovascular score 0ReferenceReference 10.71 (0.27 to 1.85)0.48 21.88 (0.50 to 7.04)0.35 32.11 (0.93 to 4.77)0.07 41.02 (0.47 to 2.24)0.96Initial CVI1.04 (0.90 to 1.20)0.62Time to first FiO~2~ wean0.99 (0.95 to 1.03)0.67Number of FiO~2~ changes in 24 h0.82 (0.68 to 0.99)0.04\*Odds ratios are presented per unit increase in respiratory subscale score. FiO~2~, fraction of inspired oxygen; AUC, area under the curve; VT/VF, ventricular tachycardia or ventricular fibrillation; TH, therapeutic hypothermia; PCAC, Pittsburgh cardiac arrest category; SOFA, sequential organ failure assessment; CVI, cumulative vasopressor index.

Secondary outcomes {#Sec11}
------------------

When we tested the association of FiO~2~AUC with outcomes, we found that in both unadjusted and adjusted analysis, higher FiO~2~AUC was associated with significantly lower odds of survival (Table [5](#Tab5){ref-type="table"}) and worse CPC at hospital discharge (Additional file [1](#MOESM1){ref-type="media"}: Table S1 and Additional file [2](#MOESM2){ref-type="media"}: Table S2). Although our model did not violate the assumption of proportional odds, stratifying patients by FiO~2~AUC quartile revealed that this effect on mortality was driven by lower survival among patients in the highest exposure quartile (OR for survival in the highest quartile compared to the lowest three quartiles 0.32 (95% CI 0.13 to 0.79), *P* = 0.003) (Figure [1](#Fig1){ref-type="fig"}).Table 5**Unadjusted and adjusted associations between predictors and odds of survival to hospital dischargeBaseline predictorOdds ratio (OR)*P*** **-valueUnadjusted OR (95% CI)**FiO~2~ AUC0.90 (0.82 to 0.98)0.02Age1.02 (1.00 to 1.04)0.10Male sex0.66 (0.19 to 1.22)0.19Out-of-hospital arrest0.66 (0.36 to 1.21)0.18Arrest rhythm VT/VF1.62 (0.87 to 3.03)0.13Received TH0.24 (0.13 to 0.48)\<0.001PCAC 1ReferenceReference 20.67 (0.26 to 1.72)0.41 30.32 (0.11 to 0.94)0.04 40.07 (0.02 to 0.22)\<0.001First P:F ratio1.00 (1.00 to 1.00)0.38Initial pulmonary compliance0.99 (0.97 to 1.02)0.68Initial SOFA-respiratory score0.23 0ReferenceReference 10.38 (0.13 to 1.11)0.08 20.94 (0.34 to 2.63)0.91 30.77 (0.29 to 2.02)0.59 41.13 (0.40 to 3.19)0.81Initial SOFA-cardiovascular score\<0.01 0ReferenceReference 10.95 (0.34 to 2.70)0.94 20.09 (0.01 to 0.71)0.02 30.31 (0.13 to 0.77)0.01 40.40 (0.17 to 0.92)0.03Initial CVI0.82 (0.69 to 0.98)0.03Time to first vent wean1.04 (1.00 to 1.10)0.08Number of vent weans in 24 h0.79 (0.64 to 0.98)0.03**Adjusted OR (95% CI)**FiO2 AUC0.86 (0.76 to 0.97)0.02Age1.01 (0.98 to 1.04)0.38Male sex0.52 (0.23 to 1.18)0.12Out-of-hospital arrest1.48 (0.52 to 4.23)0.46Arrest rhythm VT/VF1.53 (0.62 to 3.77)0.35Received TH0.19 (0.07 to 0.58)\<0.01PCAC 1ReferenceReference 21.25 (0.33 to 4.79)0.74 30.91 (0.24 to 3.51)0.89 40.13 (0.03 to 0.58)\<0.01Initial SOFA-cardiovascular score 0ReferenceReference 10.62 (0.14 to 2.69)0.52 20.05 (0.00 to 0.71)0.03 30.23 (0.04 to 1.31)0.10 40.12 (0.01 to 1.73)0.12Initial CVI1.29 (0.73 to 2.26)0.38Time to first vent wean0.78 (0.95 to 1.10)0.13Number of vent weans in 24 h1.03 (0.58 to 1.07)0.49*FiO* ~*2*~, fraction of inspired oxygen; *AU,* area under the curve; *VT/VF,* ventricular tachycardia or ventricular fibrillation; *TH,* therapeutic hypothermia; *PCAC,* Pittsburgh cardiac arrest category; *P:F,* partial pressure of arterial oxygen to fraction of inspired oxygen; *SOFA,* sequential organ failure assessment; *CVI,* cumulative vasopressor index.Figure 1**Cerebral performance category stratified by quartile of fraction of inspired oxygen area under the curve (FiO** ~**2**~ **AUC).**

Propensity score-adjusted analysis {#Sec12}
----------------------------------

The above findings were replicated in our propensity score-adjusted analysis, where only the highest quartile of FiO~2~AUC exposure was associated with increased mortality (*P* = 0.03). The change in SOFA-R and pulmonary compliance from 0 to 48 h did not differ between this quartile and the remaining three quartiles (*P* = 0.18 and *P* = 0.39, respectively). Compared to the other quartiles, the initial SOFA-R in this quartile was significantly higher (median SOFA-R = 3 versus 1, 2 and 2 in quartiles 1 to 3, respectively; *P* \<0.001). A propensity-adjusted analysis analyzing the affect of FiO~2~AUC on change in dynamic pulmonary compliance was not possible (terms were not uniquely estimable). In our propensity-adjusted analysis for change in SOFA-R from 0 to 48 h, the highest quartile of FiO~2~AUC was associated with *improved* SOFA-R compared to the lowest quartile (OR 0.41, 95% CI (0.19-0.88), *P* = 0.005) but there were no other significant differences in outcome across quartiles.

Discussion {#Sec13}
==========

We examined the association between inhaled oxygen exposure and change in pulmonary function after CA. Higher oxygen exposure in the initial 24 h was strongly associated with the presence of baseline cardiopulmonary dysfunction, but was not associated with deterioration in pulmonary compliance or gas exchange in the first 48 h after ROSC. In fact, in our propensity-adjusted analysis, CA patients in the highest quartile of oxygen exposure had *improved* lung function compared to the lowest quartile of exposure. Despite the absence of an association with change in lung function, higher inhaled oxygen levels were independently associated with decreased survival and worse neurological outcomes. Taken together, these data suggest that pulmonary oxygen toxicity is not a clinically important mediator of the association between hyperoxia and patient outcomes after CA.

A study of the Project IMPACT database found an association between arterial hyperoxia and worsened survival after CA \[[@CR8]\]. The same authors reported increasing odds of mortality in a linear fashion for PaO~2~ values in excess of 100 mmHg, suggestive of dose-dependent toxicity \[[@CR9]\]. A significant limitation of this work was the use of a single marker of hyperoxemia (that is, first PaO~2~) without regard to underlying physiologic dysfunction and without assessment of subsequent time points. Furthermore, other large database studies have failed to reproduce this finding \[[@CR32],[@CR33]\]. Unlike those prior, we have incorporated not only physiologic measures of baseline lung diffusion and cardiac function into our models, expanded our analysis beyond the initial or highest level of oxygenation, and controlled for the appropriate tendency of clinicians to increase FiO~2~ in patients with more severe cardiopulmonary dysfunction.

Our study also differs from previous work in that it examines both surrogate endpoints of pulmonary dysfunction as well as clinically meaningful endpoints. Our results reflect that oxygen exposure was increased in those with the worst early cardiopulmonary dysfunction, which one would expect if oxygen were being titrated based on the clinical assessment of the patient. There was no association between the time to first FiO~2~ wean or the total number of adjustments made in 24 h, suggesting that higher FiO~2~AUC is not a surrogate marker for less attentive care. The correlation between oxygen exposure and SOFA-R, which is based on the PaO~2~:FiO~2~ ratio, is consistent with the appropriate dosing of patients with reduced oxygen diffusive capacity with higher inspired oxygen. The loss of association when comparing early oxygen exposure to subsequent changes in measures of pulmonary dysfunction (SOFA-R or compliance) is contradictory to the notion that early oxygen toxicity results in subsequent lung injury.

Importantly, despite observing no association between oxygen exposure and pulmonary dysfunction, we observed significantly worse survival in the quartile of CA patients with the highest oxygen exposure (25% versus 50%, *P* = 0.003), which remained significant in adjusted analysis and in our propensity-adjusted analysis. This may be explained by the fact that this quartile had the highest baseline SOFA-R scores and may have been sicker than the other quartiles. However, this excess mortality is also consistent with the findings from the Project IMPACT database, although we did not observe a linear dose-response curve as they did. Rather, we observed what appears to be a threshold effect where toxicity accrued only after FiO~2~ exceeded an average of 0.75 over 24 h. If oxidative stress after CA worsens outcomes \[[@CR34]-[@CR36]\] then it is likely that neuronal injury, rather than pulmonary toxicity, drives this effect. Indeed, brain injury is the largest contributor to death after CA \[[@CR37]\], though pulmonary dysfunction may play a role, particularly after in-hospital CA \[[@CR24]\]. We hypothesize that the threshold for toxicity we observed occurs at the level of exposure at which oxidative stress exceeds antioxidant reserves. Thus, it may be most desirable to decrease FiO~2~ in patients receiving the highest oxygen exposure. Though this would seem intuitive, a recent report revealed that as many as 18% of hyperoxic patients receiving FiO~2~ \>0.80 have neither their FiO~2~ nor their PEEP weaned \[[@CR38]\].

There are limitations to our study, which are common to retrospective observational studies. Because patients in our study were not randomized, we cannot determine causality. A significant concern in this type of observational study is confounding by indication, whereby sicker patients may also be at higher risk of oxygen exposure, whether appropriate or inappropriate, due to their severity of illness. Propensity-adjusted analysis may partially control for this phenomenon, and our propensity-adjusted analysis for survival replicated our findings. Moreover, in the same propensity-adjusted analysis, those patients in the highest quartile of oxygen exposure had *improved* lung function over 24 h compared to those in the lowest quartile of exposure, further strengthening our assertion that pulmonary oxygen toxicity is not a clinically relevant phenomenon in this patient population. We believe a randomized study would be difficult to perform ethically with the present concerns over hyperoxia after CA, so well-adjusted observational studies are the highest level of evidence possible. Furthermore, our outcome measures (change in SOFA-R and dynamic pulmonary compliance) do not fully represent change in lung dysfunction or the potential for pulmonary oxygen toxicity. There are no compelling data to suggest whether compliance or oxygenation is a better measure of lung dysfunction. As P:F ratio is commonly used in studies of acute lung injury, and previous animal studies have used pulmonary dynamic compliance as a measure of lung function \[[@CR39],[@CR40]\], we chose to measure both. However, it is important to note that P:F ratio can vary across FiO~2~ irrespective of changes in pulmonary function \[[@CR41]\], and post-arrest patients often have significant changes made in FiO~2~ in the first 24 h after ROSC \[[@CR10]\]. We believe that we chose the two best measures of lung dysfunction that can be obtained in an observational clinical study, but they are nevertheless imperfect.

Since our work was retrospective, we did not perform a power calculation *a priori,* and unfortunately *post hoc* power calculations have little statistical meaning or utility \[[@CR42]\], but our main findings may have resulted from a type II error. Additionally, the observational nature of our study means that our blood gases were not all collected at standardized times and so we were forced to estimate PaO~2~:FiO~2~ ratios and SOFA-R scores using either closely timed blood gases or pulse oximetry data. Further, by limiting our analysis to CA patients who survived and were ventilated ≥24 h, we excluded both the sickest and the healthiest post-arrest patients. Patients who are extubated within 24 h after a CA generally have very good outcomes while withdrawal of care within 24 h is generally due to extremely grim prognosis. By excluding these patients, our analysis may exaggerate the magnitude of the association between oxygen exposure and mortality.

Conclusion {#Sec14}
==========

Our findings suggest that high levels of inhaled oxygen are not associated with deterioration in gas exchange or pulmonary compliance after cardiac arrest. However, oxygen exposure was associated with decreased survival to discharge and worse neurological outcomes. Taken together, it does not appear that pulmonary oxygen toxicity mediates the association between hyperoxia and poor outcomes after cardiac arrest.

Key messages {#Sec15}
============

Post-arrest patients are often exposed to 100% oxygen during cardiopulmonary resuscitation and the post-arrest period, raising concern for the potential for pulmonary oxygen toxicity.This study suggests that higher oxygen exposure is not associated with subsequent pulmonary dysfunction after cardiac arrest.At extreme levels, high oxygen exposure was associated with decreased survival to discharge, probably related to worsened neurological injury.We suggest avoiding prolonged exposure to a FiO2 \> 0.75 in the early post-arrest period unless necessary to prevent hypoxia.

Additional files {#Sec16}
================

Additional file 1: Table S1.Unadjusted associations between exposures and discharge cerebral performance category. *Abbreviations*: FiO2 -- Fraction of inspired oxygen; AUC -- Area under the curve; VT/VF -- Ventricular tachycardia or ventricular fibrillation; TH -- Therapeutic hypothermia; PCAC -- Pittsburgh Cardiac Arrest Category; P:F -- Partial pressure of arterial oxygen to fraction of inspired oxygen; SOFA -- Sequential Organ Failure Assessment; CVI -- Cumulative vasopressor index; OR -- Odds ratio.Additional file 2: Table S2.Adjusted associations between exposures and discharge cerebral performance category. Abbreviations: FiO2 -- Fraction of inspired oxygen; AUC -- Area under the curve; VT/VF -- Ventricular tachycardia or ventricular fibrillation; TH -- Therapeutic hypothermia; PCAC -- Pittsburgh Cardiac Arrest Category; SOFA -- Sequential Organ Failure Assessment; CVI -- Cumulative vasopressor index; OR -- Odds ratio.
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